AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL – Get Free Report)’s share price fell 2.6% during mid-day trading on Friday. The stock traded as low as $13.24 and last traded at $13.25. 1,893,665 shares changed hands during trading, an increase of 122% from the average daily volume of 852,805 shares. The stock had previously closed at $13.61.
AGF U.S. Market Neutral Anti-Beta Fund Trading Down 2.6%
The firm has a market capitalization of $336.55 million, a PE ratio of 17.49 and a beta of -0.68. The business has a 50-day moving average of $12.50 and a 200 day moving average of $12.66.
Hedge Funds Weigh In On AGF U.S. Market Neutral Anti-Beta Fund
Hedge funds have recently bought and sold shares of the company. CoreCap Advisors LLC bought a new position in AGF U.S. Market Neutral Anti-Beta Fund during the second quarter valued at about $36,000. Bank of New York Mellon Corp raised its position in AGF U.S. Market Neutral Anti-Beta Fund by 59.4% in the first quarter. Bank of New York Mellon Corp now owns 27,235 shares of the company’s stock worth $380,000 after acquiring an additional 10,146 shares during the period. Farther Finance Advisors LLC raised its position in AGF U.S. Market Neutral Anti-Beta Fund by 939.7% in the third quarter. Farther Finance Advisors LLC now owns 42,356 shares of the company’s stock worth $508,000 after acquiring an additional 38,282 shares during the period. Collaborative Fund Advisors LLC bought a new stake in AGF U.S. Market Neutral Anti-Beta Fund in the third quarter worth about $1,794,000. Finally, Crescent Grove Advisors LLC bought a new stake in AGF U.S. Market Neutral Anti-Beta Fund in the first quarter worth about $6,614,000.
About AGF U.S. Market Neutral Anti-Beta Fund
The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.
Further Reading
- Five stocks we like better than AGF U.S. Market Neutral Anti-Beta Fund
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for AGF U.S. Market Neutral Anti-Beta Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AGF U.S. Market Neutral Anti-Beta Fund and related companies with MarketBeat.com's FREE daily email newsletter.
